We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Egalet Morphine Pill with Narrow Abuse-Deterrent Label
FDA Approves Egalet Morphine Pill with Narrow Abuse-Deterrent Label
The FDA approved Egalet’s extended-release morphine tablet, Arymo ER, for daily, around-the-clock pain treatment, with labeling describing physical properties that can deter abuse through injection. However, abuse by nasal and oral routes is still possible, the agency said.